Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/30/2025

First-Line Treatment for Strep Throat

Primary Treatment Regimens

  • The American Academy of Pediatrics recommends amoxicillin 50 mg/kg once daily (maximum 1000 mg) or 25 mg/kg twice daily (maximum 500 mg per dose) for 10 days as the preferred regimen for non-allergic patients due to better palatability in children and equivalent efficacy 1, 2
  • Penicillin V is recommended for children at 250 mg twice or three times daily for 10 days, and for adolescents/adults at 250 mg three to four times daily or 500 mg twice daily for 10 days, based on guidelines from the Infectious Diseases Society of America 3
  • For non-immediate (non-anaphylactic) allergy, first-generation cephalosporins such as cephalexin 20 mg/kg twice daily (maximum 500 mg per dose) or cefadroxil 30 mg/kg once daily (maximum 1 gram) for 10 days are preferred, with strong, high-quality evidence supporting their use 4, 2
  • For immediate/anaphylactic allergy, clindamycin 7 mg/kg three times daily (maximum 300 mg per dose) for 10 days is recommended, with azithromycin 12 mg/kg once daily (maximum 500 mg) for 5 days being an alternative option 4, 2

Critical Treatment Principles

  • The Centers for Disease Control and Prevention recommend that all antibiotics, except azithromycin, require a full 10-day course to achieve maximal pharyngeal eradication and prevent acute rheumatic fever, even if symptoms resolve earlier 4, 1, 2
  • Azithromycin requires only 5 days due to its prolonged tissue half-life, as stated by the American Academy of Pediatrics 4
  • Therapy can be safely postponed up to 9 days after symptom onset and still prevent rheumatic fever, according to the Infectious Diseases Society of America 4
  • Patients are no longer contagious after 24 hours of appropriate antibiotic therapy, but must complete the full course, as recommended by the American Academy of Pediatrics 1

Important Considerations and Pitfalls

  • Macrolide resistance among Group A Streptococcus ranges from 5-8% in the United States, but varies geographically, according to the Centers for Disease Control and Prevention 4
  • Local resistance patterns should be considered before prescribing azithromycin or clarithromycin, as recommended by the Infectious Diseases Society of America 4, 2
  • Clindamycin resistance is approximately 1% in the United States, as reported by the Centers for Disease Control and Prevention 4
  • Up to 10% of patients with immediate penicillin hypersensitivity may have cross-reactivity with first-generation cephalosporins, according to the American Academy of Allergy, Asthma, and Immunology 3, 4

Adjunctive Therapy

  • Acetaminophen or NSAIDs (ibuprofen) can be used for moderate to severe symptoms or high fever, as recommended by the American Academy of Pediatrics 4
  • Aspirin should be avoided in children due to the risk of Reye syndrome, as warned by the Centers for Disease Control and Prevention 4
  • Corticosteroids should not be used as adjunctive therapy, according to the Infectious Diseases Society of America 4

Special Situations

  • Intramuscular penicillin can be used for patients unlikely to complete a full 10-day oral course, as recommended by the Infectious Diseases Society of America 3
  • It is not necessary to perform throat cultures or treat asymptomatic household contacts, except in situations with increased risk of frequent infections or non-suppurative sequelae, as stated by the American Academy of Pediatrics 3
  • Routine follow-up throat cultures are not recommended for asymptomatic patients who have completed therapy, according to the Infectious Diseases Society of America 4

Cefdinir Dosing for Group A Streptococcal Pharyngitis

Critical Context and Treatment Guidelines

  • The Infectious Diseases Society of America recommends that cefdinir should only be used for GAS pharyngitis in patients with non-immediate penicillin allergy who cannot tolerate first-generation cephalosporins, due to its moderate-quality evidence and higher cost 5, 6
  • Penicillin or amoxicillin remains the drug of choice for all non-allergic patients, with strong, high-quality evidence supporting its efficacy, narrow spectrum, safety, and low cost 5, 6

Preferred Treatment Options

  • For non-anaphylactic penicillin allergy, first-generation cephalosporins are strongly preferred over cefdinir due to stronger evidence quality, narrower spectrum of activity, lower cost, and essentially zero resistance rates among GAS 5, 6
  • The American Academy of Pediatrics and the Infectious Diseases Society of America recommend a full 10-day course of antibiotics to achieve maximal pharyngeal eradication of Group A Streptococcus and prevent acute rheumatic fever 5, 6

Alternative Treatment Options

  • For patients with immediate hypersensitivity reactions to penicillin, clindamycin 7 mg/kg three times daily (maximum 300 mg/dose) for 10 days is a preferred alternative due to its low resistance rate 5, 6
  • Azithromycin 12 mg/kg once daily (maximum 500 mg) for 5 days is an acceptable alternative, but its use is limited by 5-8% macrolide resistance in the US 5, 6

Management of Acute Group A Streptococcal Pharyngitis in Children

First‑Line Antimicrobial Therapy

  • Penicillin or amoxicillin is the drug of choice for all non‑allergic patients with acute Group A streptococcal (GAS) pharyngitis; high‑quality, strong evidence supports its use and there is no documented penicillin resistance worldwide. 7, 8
  • For uncomplicated acute GAS pharyngitis in a child weighing ~32 kg, the preferred regimen is amoxicillin 800 mg (≈25 mg/kg) twice daily for 10 days, or 1600 mg once daily if adherence is a concern. This dosing provides effective bacterial eradication with a narrow spectrum and low cost. 7, 8

Alternative Regimens for Penicillin Allergy

  • Non‑anaphylactic penicillin allergy: First‑generation cephalosporins (e.g., cephalexin 640 mg, ≈20 mg/kg) twice daily for 10 days are recommended; strong, high‑quality evidence indicates only ~0.1 % cross‑reactivity with penicillins. 7
  • Immediate/anaphylactic penicillin allergy: Clindamycin 224 mg (≈7 mg/kg) three times daily (max 300 mg per dose) for 10 days is optimal; resistance among GAS in the United States is ~1 %. 7
  • Macrolide alternative: Azithromycin 384 mg (≈12 mg/kg) once daily (max 500 mg) for 5 days is acceptable, but macrolide resistance ranges from 5 % to 8 % in the United States and varies geographically. 7

Treatment Duration and Course Completion

  • A full 10‑day antimicrobial course is mandatory to achieve maximal pharyngeal eradication of GAS and to prevent acute rheumatic fever, even when symptoms resolve within 3–4 days. 7, 8
  • Shortening the course by even a few days leads to appreciable increases in treatment‑failure rates and rheumatic‑fever risk. 7, 8
  • The only exception to the 10‑day rule is the 5‑day azithromycin regimen, which has been validated for efficacy. 7, 8

Avoidance of Inappropriate Therapy

  • Augmentin (amoxicillin‑clavulanate) should not be used for standard acute GAS pharyngitis; it broadens antimicrobial spectrum, raises cost, and provides no outcome benefit over amoxicillin alone. 7, 8
  • Do not substitute two lower‑strength Augmentin tablets for one higher‑strength tablet, as this results in excess clavulanate exposure and increased gastrointestinal side effects. (Note: this recommendation is based on clinical practice guidelines, not a specific citation.)
  • Do not shorten the antimicrobial course below 10 days (except for the validated azithromycin 5‑day regimen), as this markedly raises failure and rheumatic‑fever risk. 7, 8

Adjunctive Symptomatic Management

  • Acetaminophen or ibuprofen may be offered for moderate to severe sore throat or high fever; strong, high‑quality evidence supports their effectiveness in reducing pain and inflammation. 7
  • Aspirin must be avoided in children because of the risk of Reye syndrome. 7
  • Systemic corticosteroids are not recommended as adjunctive therapy for acute GAS pharyngitis. 7